美国波士顿消息:1972年美国国立癌症研究所的一名人员称,对皮肤黑色素瘤的动物模型经皮内注入卡介苗(BCG)在癌症治疗方面是一重大的突破。美国食品和药物管理局(FDA)目前虽然尚未批准以任何方式的BCG治疗癌症,但减毒的牛结核菌已开始代替药物,用于血管内治疗浅表的、复发的膀胱癌和膀胱原位癌。波士顿大学泌尿科副教授Richard Babayan说,BCG比用过的其他药物更有效,疗程结束后BCG的作用似乎至少可维持 Boston, USA: In 1972, a member of the National Cancer Institute in the United States stated that an intradermal injection of BCG into an animal model of skin melanoma is a major breakthrough in cancer treatment. Although the U.S. Food and Drug Administration (FDA) has not yet approved BCG in any way for the treatment of cancer, attenuated bovine tuberculosis has begun to replace drugs for intravascular treatment of superficial, recurrent bladder cancer and bladder in situ cancer. Richard Babayan, an associate professor of urology at Boston University, said that BCG is more effective than other drugs that have been used, and that BCG seems to be at least as effective as the course of treatment.